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Summary
Alcohol and other drug (AOD) treatment services aim to support people to reduce harmful AOD use. 
Clients accessing these services often receive multiple episodes of treatment, with some clients 
requiring more intensive treatment (for example, more episodes of treatment) to achieve their goals.
Using the Alcohol and Other Drug Treatment Services National Minimum Data Set (AODTS NMDS), 
this report examines the treatment patterns of clients who received treatment from publicly funded 
specialist AOD services in the study period 1 July 2014 to 30 June 2019 (that is, 5 collection periods) 
for 3 client cohorts.
The 3 cohorts were those undertaking:
• intensive treatment (6,695 clients, or 3.2%)—clients who received 7 or more closed treatment 
episodes	across	at	least	3	collection	periods	(that	is,	financial	years)
• recurring treatment (14,292 clients, or 6.8%)—clients who received fewer than 7 closed 
treatment episodes across at least 3 collection periods
• non-recurring treatment (190,062 clients, or 90%)—clients who received treatment in fewer than 
3 collection periods.
Clients who received intensive treatment were more likely to be female and less 
likely to live in disadvantaged or remote areas than clients who received recurring 
and non-recurring treatment
The cohort of clients that received intensive treatment had the highest percentage of females (41%) 
and clients residing in the least disadvantaged socioeconomic areas (18%). They were also less likely 
to live in Outer regional, Remote and Very remote areas (15%) than other clients. 
Clients who received intensive treatment were more likely than clients who 
received recurring and non-recurring treatment to report multiple principal drugs 
of concern
Among all AOD clients, irrespective of their treatment cohort, alcohol was the most common 
principal drug of concern (PDOC) and counselling was the most common main treatment type.
Almost 2 in 3 (61%) clients who received intensive treatment reported multiple PDOC across 
episodes, compared with 53% for recurring and 11% for non-recurring treatment.
7	in	10	(70%)	clients	who	received	intensive	treatment	received	at	least	3	different	main	treatment	
types, compared with 25% for recurring and 3.1% for non-recurring treatment.
Clients who received either intensive or recurring treatment were more likely to 
end their last reported treatment episode in the study period with an unplanned 
cessation compared with previous treatment episodes
Clients who received intensive treatment were more likely to record an unplanned cessation for 
their last reported episode in the study period (26%) compared with all episodes (18%). This was 
also true for clients who received recurring treatment (31% for the last reported episode and 26% 
across all episodes). 
vi Patterns of intensive alcohol and other drug treatment service use in Australia: 1 July 2014 to 30 June 2019
Clients who received intensive treatment did not follow a dominant  
treatment pattern
Clients	who	received	intensive	treatment	received	many	different	combinations	of	treatment	 
with no dominant pattern. For example, clients who received treatment for the most common 
PDOC—alcohol—followed	over	500	different	patterns	of	treatment.
Further	development	of	the	AODTS	NMDS	data	collection	could	provide	more	
comprehensive information about why people cease treatment
This analysis does not include information about treatment outcomes or severity of dependence. 
Outcomes and severity of dependence may be associated with the number of episodes clients 
receive, but it is not clear what that relationship is. For example, non-recurring clients may leave 
treatment	because	they	met	their	treatment	goals	or,	conversely,	due	to	difficulties	with	treatment	
access. Inclusion of outcome data items in the AODTS NMDS could provide more information about 
why clients cease or return to treatment.
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1 Introduction
The use of alcohol and other drugs (AOD) is an ongoing public health concern in Australia.  
At	the	population	level,	substance	use	poses	a	significant	health,	social	and	economic	challenge	
(see Box 1.1). This is because AOD use is associated with person-level harms, including physical 
injury, psychological distress and mental health conditions, involvement in criminal activity, risky 
behaviours, preventable disease and mortality (ABS 2019; AIHW 2017, 2019a). 
Box	1.1:	Health,	social	and	economic	impacts	of	AOD	use	in	Australia
Health impacts
• The health impacts associated with AOD use include hospitalisation, mental health 
conditions, physical injury, overdose and mortality.
• Tobacco, alcohol and illicit drug use together account for 16.5% of the burden of disease 
in Australia (AIHW 2019a).
Social impacts
• The social impacts of AOD use in Australia include involvement in criminal activity, 
engagement in risky behaviours, victimisation and road trauma.
• In 2016, 1 in 10 (9.9%) recent drinkers and 15.1% of people who had recently used illicit 
drugs had driven while intoxicated (AIHW 2017).
• In 2019, 1 in 5 (21%) Australians aged 14 and over were victims of an alcohol-related 
incident and 10.5% were victims of an illicit drug-related incident (AIHW 2020a).
Economic impacts
• Most of the economic impacts associated with AOD use relate to health care, criminal 
justice system expenditure and mortality.
• In 2015–16, the estimated cost of tobacco use was $136.9 billion (Whetton et al. 2019).
• Use of opioids ($15.8 billion) and cannabis ($4.5 billion) also presented substantial 
economic costs in 2015–16 (Whetton et al. 2020a, 2020b).
• In 2013–14, the estimated cost of methamphetamine use was more than $5 billion 
(Whetton et al. 2016).
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1.1 Policy context
An individual’s AOD use is dependent on a range of factors, including social, environmental and 
economic circumstances (Spooner 2009). Therefore, the implementation of evidence-based policies 
that are targeted at reducing AOD-related harms are increasingly important for shaping the 
patterns of AOD treatment service use in Australia.
National	Drug	Strategy	2017–2026
The National Drug Strategy (NDS) 2017–2026 provides a framework for a coordinated approach to 
minimising harm related to AOD use in Australia. The purpose of the NDS 2017–2026 is to build ‘safe, 
healthy and resilient Australian communities through preventing and minimising alcohol, tobacco 
and other drug-related health, social and economic harms’ (DoH 2017). The NDS is guided by  
3 pillars of harm minimisation—demand reduction, supply reduction and harm reduction  
(DoH 2017). Together, these pillars aim to prevent, manage and reduce the:
• uptake and misuse of AOD
• supply and production of AOD
• social, health and economic costs of AOD.





The National Framework for Alcohol, Tobacco and Other Drug Treatment 2019–2029 aims to ensure 
that all Australians can ‘access high quality treatment appropriate to their needs’ (DoH 2019). The 
framework	focuses	on	treatment	interventions	for	AOD	use,	and	provides	an	overview	of	effective	
treatment principles.
The framework describes intensive treatment interventions as those with a key focus on ‘changing 






As such, intensive interventions can be broadly characterised as those that are likely to require 
ongoing support and continued contact with a client (DoH 2019).
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1.2 Alcohol and other drug treatment
AOD treatment services aim to provide support to people to reduce substance use, facilitate 
lifestyle change and improve overall health and wellbeing (AIHW 2020b). While treatment objectives 
vary, successful AOD treatment often involves multiple episodes of care (Kelly et al. 2019; Lubman 
et al. 2014). For example, a treatment pattern might include assessment, supervised withdrawal or 
rehabilitation, and multiple episodes of follow-up counselling (Lubman et al. 2014).
Notably, some clients receive more intensive treatment (that is, more episodes) than others. Factors 
such as principal drug of concern (PDOC) and treatment type are associated with treatment success 
and, potentially, number of treatment episodes (Lubman et al. 2014). However, the characteristics  
of clients who receive intensive treatment are relatively poorly understood. Additionally, it is not 
clear whether clients who receive intensive treatment follow similar patterns through treatment  
(for example, similar sequences of treatment types).
Previous research
Previous AIHW analysis examined treatment patterns using data from the Alcohol and Other Drug 
Treatment Services National Minimum Data Set (AODTS NMDS) (AIHW 2019b). This analysis revealed 
that a small proportion of clients (3%) treated in publicly funded AOD agencies received ‘continuous 
treatment’; that is, at least 1 treatment episode in each collection period between 1 July 2014 and  
30 June 2018 (AIHW 2019b). These clients however, accounted for 13% of total treatment episodes.
1.3 Purpose
The purpose of this report is to strengthen the evidence base for clients who have received multiple 
episodes of specialist AOD treatment over an extended period of time. Understanding these 
treatment patterns will help to inform the provision of policies and programs that reduce  
AOD-related harm, and better support client needs. This is important because people receiving 
AOD treatment often require ongoing support to implement lasting change and achieve their 
treatment goals (DoH 2019).
Therefore, this report aims to answer the research question:
What are the patterns of service use for clients who received intensive AOD treatment?
In doing so, this report seeks to identify clients who received intensive treatment from a publicly 
funded AOD treatment service, and characterise their service use patterns to inform policy and 
service planning. The report also seeks to compare characteristics of clients in this cohort with 
those who received less intensive treatment (that is, recurring or non-recurring treatment).
This report addresses a gap in knowledge about the patterns of AOD treatment service use in 
Australia by:
• establishing criteria for clients receiving intensive AOD treatment
• identifying the characteristics of clients who received intensive AOD treatment
• investigating whether common patterns of treatment service use were evident among clients 
who received intensive AOD treatment and, if so, how these compare with other client cohorts.
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1.4 Alcohol and other drug treatment services in Australia
The AODTS NMDS is collected annually by the Australian Institute of Health and Welfare (AIHW) 
to monitor treatment episodes and contribute to the development of policy and service planning 
(AIHW 2020b). See Box 1.2 for information about the AODTS NMDS.
Box	1.2:	Alcohol	and	Other	Drug	Treatment	Services	National	Minimum	Data	Set	
The AODTS NMDS contains information on treatment provided to clients by publicly funded 
AOD treatment services, including government and non-government agencies. Clients include 
people who are seeking assistance for their own drug use, and those seeking assistance 
for someone else’s drug use. Information on clients is included in the AODTS NMDS when a 
treatment episode is closed (see Glossary).
Client information is collected at the episode level in the AODTS NMDS. A statistical linkage 
key (SLK) was introduced in 2012–13, which enables the number of individual clients receiving 
treatment to be estimated. The SLK is constructed from information about the client’s date of 
birth, sex and selected letters of their name.
Imputation was applied for selected AODTS NMDS data items in instances where the response 
rate	fell	below	an	agreed	cut-off	in	the	states	and	territories.	Imputation	was	undertaken	for	
the 2012–13, 2013–14 and 2015–16 collections (see the relevant Data Quality Statements for 
previous collection years for more detail). Analysis of the SLK data showed that approximately 
99%	of	national	data	contained	a	valid	SLK	in	2018–19,	reflecting	high	response	rates	and	
improved SLK quality for all jurisdictions. The analysis in this report is based on AODTS NMDS 
data from 2013–14 to 2018–19. This is because, as a pilot collection, the 2012–13 SLK has data 
quality issues.
Coverage and data quality 
Although the AODTS NMDS collection covers most publicly funded AOD treatment services, 
including	government	and	non-government	agencies,	it	is	difficult	to	fully	quantify	the	scope	of	AOD	
services in Australia. According to Ritter and others (2014), AOD treatment comprises 1.6 million 
episodes, services or contacts each year. Of these, the AODTS NMDS accounts for an estimated 10% 
of treatment episodes, and between 20%–30% of individual clients who received AOD treatment in 
Australia.
Further details on scope, coverage and data quality is available from the AODTS NMDS Data Quality 
Statement. This report includes cross-references to supplementary tables (denoted as ‘SC’ or ‘SE’), 
which are available at https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/
patterns-of-intensive-aod-treatment-2014-to-2019/data. 
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2	 Defining	intensive	AOD	treatment
For	the	purposes	of	this	report,	a	set	of	criteria	for	defining	intensive	AOD	treatment	was	
established. The criteria were based on both the number of collection periods and number of 
treatment episodes that a client received within the study period. See Appendix A for further 
information	on	intensive	treatment	definitions	and	Appendix	B	for	information	on	logistic	modelling	
methodology and jurisdictional results.
2.1	 What	is	intensive	AOD	treatment?
Clients receiving intensive treatment—clients who received 7 or more closed treatment 
episodes across at least 3 collection periods (see Figure 2.1).
This	definition	can	be	broken	down	into	2	key	criteria:
Criterion 1: the client received AOD treatment in at least 3 collection periods.
Criterion 2: the client received an overall total of at least 7 closed treatment episodes.



































2014–15 2015–16 2017–182016–17 2018–19
Collection period
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2.2	 What	is	recurring	AOD	treatment?
Clients receiving intensive treatment—clients who received fewer than 7 closed treatment 
episodes across at least 3 collection periods (see Figure 2.2).
This	definition	can	be	broken	down	into	2	key	criteria:
Criterion 1: the client received AOD treatment in at least 3 collection periods.
Criterion 2: the client received fewer than 7 closed treatment episodes total.
Please note: clients must have received a minimum of 3 episodes to appear in 3 collection 
periods.
















Treatment: Support and case 
management only
2014–15 2015–16 2017–182016–17 2018–19
Collection period
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2.3	 What	is	non-recurring	AOD	treatment?
Clients receiving non-recurring treatment—clients who received treatment in fewer than  
3 collection periods (see Figure 2.3).
This	definition	has	1	key	criterion:
Criterion 1: clients received only closed episodes of treatment in 1 or 2 collection periods.
Figure	2.3	Example	of	non-recurring	AOD	treatment
2.4 Analysis criteria
Clients were excluded from the analysis if they:
• received a closed treatment episode between 1 July 2013 and 30 June 2014
• received	their	first	recorded	closed	treatment	episode	between	1	July	2017	and	30	June	2019
• were referred from another AOD treatment service for their initial episode in the 2014–15 
collection period
• received treatment only for another person’s AOD use
• reported ‘assessment only’ as their main treatment type for all episodes.
These criteria provided a proxy start date by ensuring that the initial cohort received treatment 
for their own drug use, and did not receive AOD treatment in the 12 months before 1 July 2014. 
They also ensured that there was enough time for clients to have received treatment in 3 or more 
collection periods. However, it is important to note that clients may have received treatment before 
1 July 2013, and/or continued to receive treatment beyond 30 June 2019. Services accessed in these 
periods are outside the scope of this report. Episodes with ‘assessment only’ as the main treatment 
type were also out of scope of the criteria of this analysis. This is because assessment-only 
treatment episodes focus primarily on identifying harmful AOD use and assessing clients’ needs, 









Treatment: Support and 
case management only
2014–15 2015–16 2017–182016–17 2018–19
Collection period
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2.5 Rationale
The	rationale	for	defining	intensive	AOD	treatment	was	based	on	the	understanding	that:
• treatment experiences vary among individuals
• there is a subset of clients which engages with AOD treatment services more regularly than 
others, and therefore has a higher level of contact with the sector over time (AIHW 2019b;  
Kelly & White 2011).
This report focuses on the 211,049 clients who received AOD treatment between 1 July 2014 and 
30	June	2019	(Figure	2.4).	Three	cohorts	of	clients	were	then	identified	based	on	the	patterns	of	
treatment received:
• intensive AOD treatment
• recurring AOD treatment
• non-recurring AOD treatment.










Distinct clients (clients with a valid SLK) who 














Clients who received treatment in 2013–14 
(108,900),	clients	who	received	their	first	
episode of treatment in 2017–18 or 2018–19 
(140,156), clients who were referred to their 
first	treatment	episode	in	2014–15	from	
another AOD service (5,280), and clients who 
only received main treatment  
types of ‘assessment only’ (27,626).
 281,962 clients in total excluded
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3 Characteristics of clients who received   
	 intensive	AOD	treatment
3.1	 Who	received	intensive	AOD	treatment?
A total of 6,695 clients received intensive AOD treatment (Table SC.1). This accounts for 3.2% of all 
clients, but 16% of all closed treatment episodes.
More than half (56%)  
lived in Major cities.
Nearly 3 in 5 (59%) were male.
20–39 yrs
More than half (57%) 
were aged 20–39. 
Almost 1 in 7 (13% or 859 clients)  
identified	as	Indigenous	Australians.




A total of 14,292 clients received recurring AOD treatment (Table SC.1). This accounts for 6.8% of all 
clients, but 14% of all closed treatment episodes.
Close to half (47%)  
lived in Major cities.
Around 2 in 3 (67%) were male.
20–39 yrs
Around 3 in 5 (61%) 
were aged 20–39. 
Almost 1 in 6 (17% or 2,426 clients)  
identified	as	Indigenous	Australians.
More than 1 in 5 (22%) lived in the most  
socioeconomically disadvantaged areas.
Of	the	14,292	clients	who	received	recurring	treatment:
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3.3	 Who	received	non-recurring	AOD	treatment?
A total of 190,062 clients received non-recurring AOD treatment (Table SC.1). This accounts for 90% 
of all clients, but 70% of all closed treatment episodes.
Close to half (47%)  
lived in Major cities.
More than 2 in 3 (69%) were 
male.
20–39 yrs
More than half (54%) 
were aged 20–39. 
Around 1 in 7 (14% or 26,335 clients)  
identified	as	Indigenous	Australians.








Compared with clients who received either recurring or non-recurring AOD treatment, clients 
who received intensive AOD treatment had:
• the highest proportion of females (41%)
• the highest proportion residing in the least socioeconomically disadvantaged areas (18%).
Recurring AOD treatment
Compared with clients who received either intensive or non-recurring AOD treatment, clients 
who received recurring AOD treatment had:
• the highest proportion aged 20–29 and 30–39 (31% and 30%, respectively)
• the	highest	proportion	who	identified	as	Indigenous	Australians	(17%).
Non-recurring AOD treatment
Compared with clients who received either intensive or recurring AOD treatment, clients who 
received non-recurring AOD treatment had:
• the highest proportion of males (69%)
• the highest proportion aged 10–19 (16%).
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Sex and age
Across all cohorts receiving AOD treatment, the majority of clients were male. However, proportions 
differed	depending	on	whether	these	clients	received	intensive,	recurring	or	non-recurring	AOD	
treatment:
• Clients who received intensive AOD treatment were more likely to be female (41%) compared 
with those who received recurring (33%) or non-recurring (31%) AOD treatment (Table 3.1).
• Clients receiving recurring AOD treatment had the highest proportion of clients aged 20–29 and 
30–39 (31% and 30%, respectively) (Table 3.1).
• Male clients who received intensive AOD treatment were most commonly aged 30–39 (30%), 




there was variation across the cohorts. For example, clients who received recurring AOD treatment 
were more likely to identify as Indigenous Australians (17%, or 2,426 clients) compared with clients 




Index of Relative Socio-economic Disadvantage (IRSD). The IRSD was derived from the postcode 
of	the	client’s	last	known	home	address	at	the	start	of	the	first	treatment	episode.	Proportions	
were relatively consistent across socioeconomic groups. There were some variations depending on 
whether clients received intensive, recurring or non-recurring AOD treatment. For example, clents 
who received intensive AOD treatment were more likely to reside in the least socioeconomically 
disadvantaged areas (18%) compared with clients who received recurring and non-recurring AOD 
treatment (both 14%) (Table 3.1).
Remoteness area
Remoteness area was derived from the postcode of the client’s last known home address at the 
start	of	the	first	treatment	episode.	Across	all	cohorts	receiving	AOD	treatment,	the	majority	
of clients lived in Major cities.	However,	proportions	differed	depending	on	whether	the	clients	
received intensive, recurring or non-recurring AOD treatment. For example:
• Clients who received intensive AOD treatment were more likely to live in Major cities (56%) than 
clients who received either recurring or non-recurring AOD treatment (both 47%) (Table 3.1).
• Clients who received intensive AOD treatment were less likely to live in Outer regional, Remote 
and Very remote areas (15% combined) than clients who received either recurring or non-
recurring AOD treatment (both 26%). However, this could be due to a range of factors, including 
accessibility of treatment services and travel time.  
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Table	3.1:	AOD	treatment	service	client	profile	(%)
Characteristics Intensive Recurring Non-recurring
Sex Male 58.5 67.2 69.1
Female 41.4 32.8 30.8
Total 100.0 100.0 100.0
Age 10–19 13.2 12.2 16.2
20–29 28.1 30.6 29.8
30–39 29.3 30.1 24.5
40–49 19.3 18.5 17.6
50–59 7.8 6.8 8.1
60 and over 2.2 1.7 3.8
Total 100.0 100.0 100.0
Indigenous status Indigenous 12.8 17.0 13.9
Non-Indigenous 83.5 79.3 82.2
Not stated 3.6 3.7 4.0
Total 100.0 100.0 100.0
Socioeconomic 
disadvantage
1 (most disadvantaged) 18.3 22.0 22.2
2 19.6 21.5 21.4
3 20.4 20.1 21.0
4 19.3 17.9 18.1
5 (least disadvantaged) 18.2 14.3 14.2
Unknown socioeconomic area 4.3 4.2 3.2
Total 100.0 100.0 100.0
Remoteness area Major cities 55.5 46.5 46.9
Inner regional 25.6 24.4 24.4
Outer regional 11.0 15.6 16.3
Remote 2.3 5.5 5.8
Very remote 2.1 4.9 4.1
Unknown remoteness area 3.5 3.2 2.4
Total 100.0 100.0 100.0
Notes 






Sources: Tables SC.2, SC.3, SC.4, SC.5 and SC.6.
13Patterns of intensive alcohol and other drug treatment service use in Australia: 1 July 2014 to 30 June 2019
4	 Patterns	of	service	use	among	clients		 	
	 who	received	intensive	AOD	treatment
4.1 Principal drug of concern
For	how	many	principal	drugs	of	concern	did	clients	receive	treatment?
Clients receiving either recurring or intensive treatment were more likely to report multiple PDOC 
than clients receiving non-recurring treatment. Clients receiving intensive treatment were the most 
likely cohort to receive treatment for 3 or more PDOC (Figure 4.1; Table 4.1). In particular:
• One-quarter (25%) of clients receiving intensive treatment reported 3 or more PDOC across their 
treatment episodes, compared with 12% of clients receiving recurring treatment and 0.9% of 
those receiving non-recurring treatment.
• Clients receiving recurring (41%) or intensive (36%) treatment were more likely to report 2 PDOC 
than clients with non-recurring treatment (10%).
• Almost 9 in 10 (89%) clients receiving non-recurring treatment reported a single PDOC, 
















1 PDOC 2 PDOC 3 or more PDOC
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What	drugs	of	concern	did	clients	receive	treatment	for?	
Alcohol was the most common PDOC reported in each of the cohorts. Among clients with a single 
PDOC, amphetamines and cannabis were the second and third most common PDOC in each of 
the 3 cohorts. Clients receiving either recurring or intensive treatment were more likely to receive 
treatment for amphetamines than cannabis, while for clients receiving non-recurring treatment, the 
opposite was found (Table 4.1).
Among clients who received intensive treatment and reported a single PDOC across all episodes, 
the most common was alcohol (58% of clients), followed by amphetamines (26%) and cannabis 
(8.9%) (Table 4.1). These 3 PDOC were also the most common PDOC for clients who received 
treatment	for	multiple	PDOC	across	treatment	episodes.	More	specifically:
• Almost one-quarter (23%) of clients who received intensive treatment for 2 PDOC reported 
cannabis and amphetamines as their PDOC, and 17% reported amphetamines and other drugs 
(Table 4.1).
• Among clients who received intensive treatment for 3 or more PDOC, the top 3 drug 
combinations were: alcohol, amphetamines and cannabis (17%); amphetamines, cannabis and 
other drugs (16%); and alcohol, amphetamines and other drugs (13%).
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Table	4.1:	Proportion	of	clients	by	number	of	PDOC	and	drug	type,	clients	with	
intensive, recurring, and non-recurring treatment
Characteristics Intensive Recurring Non-recurring
Number	of	PDOC 1 39.5 47.3 88.7
2 35.6 40.6 10.4
3 or more PDOC 24.9 12.1 0.9
Total 100 100 100
Clients	with	1	PDOC Alcohol 57.8 44.0 32.8
Amphetamines 26.0 31.3 18.0
Cannabis 8.9 14.8 31.9
Heroin 3.8 4.2 3.1
Other 3.4 5.7 14.1
Total 100 100 100
Clients	with	2	PDOC Alcohol and amphetamines 13.9 12.5 10.6
Alcohol and cannabis 13.5 14.7 15.1
Alcohol and heroin 1.9 1.3 1.2
Alcohol and other 14.7 10.1 14.4
Amphetamines and cannabis 23.2 22.1 18.9
Amphetamines and heroin 4.1 4.4 3.1
Amphetamines and other 17.4 19.7 17.1
Cannabis and other 5.5 7.7 12.4
Cannabis and heroin 0.9 1.0 1.2
Heroin and other 4.9 6.6 6.0
Total 100 100 100
Clients with 3 or more 
PDOC
Alcohol, amphetamines, cannabis 17.4 18.3 15.6
Alcohol, amphetamines, heroin 3.2 2.0 2.0
Alcohol, amphetamines, other 12.8 16.6 17.8
Alcohol, cannabis, heroin 0.6 0.8 1.0
Alcohol, cannabis, other 10.0 10.8 14.0
Alcohol, heroin, other 4.1 3.7 5.3
Amphetamines, cannabis, heroin 2.8 3.5 2.4
Amphetamines, cannabis, other 16.1 21.2 22.9
Amphetamines, heroin, other 8.2 10.9 9.9
Cannabis, heroin, other 2.9 4.2 3.9
Alcohol, amphetamines, cannabis, heroin 1.1 0.7 0.2
Alcohol, amphetamines, cannabis, other 10.7 4.1 3.6
Alcohol, amphetamines, heroin, other 3.4 0.9 0.5
Alcohol, cannabis, heroin, other 1.4 0.8 0.3
Amphetamines, cannabis, heroin, other 3.8 1.3 0.6
5 PDOC 1.5 0.2 0.0
Total 100 100 100
Note: Percentage distributions may not sum to 100 due to rounding.
Sources: Tables SC.8 and SC.9.
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4.2	 Main	treatment	type
The	National	Framework	for	Alcohol,	Tobacco	and	Other	Drug	Treatment	2019–2029	identifies	4	
treatment types that are considered intensive: counselling, withdrawal management, rehabilitation 
and pharmacotherapy (DoH 2019). In this report, pharmacotherapy was included in the ‘other’ 
category because of small numbers. This is because most pharmacotherapy services are  
outside the scope of the AODTS NMDS. Therefore, the data presented here are a substantial under-
representation. More information on opioid pharmacotherapy in Australia is available from the 
AIHW’s National Opioid Pharmacotherapy Statistics Annual Data collection. Given this, the following 
sections focus on counselling, withdrawal management, rehabilitation and ‘other’ (pharmacotherapy 
and support and case management).
How	many	main	treatment	types	did	clients	receive?
The number of treatment types that clients received across treatment episodes was higher for 
clients who received intensive treatment than for those who received either recurring or  
non-recurring treatment. Over 9 in 10 (94%) clients receiving intensive treatment received more 
than 1 of the 4 treatment types (counselling, withdrawal management, rehabilitation and ‘other’) 
across episodes (Figure 4.2; Table 4.2):
• Clients receiving non-recurring treatment were the most likely to report receiving 1 treatment 
type (81%), while clients receiving recurring treatment were the most likely to receive  
2 treatment types (50%) and clients receiving intensive treatment were the most likely to  
receive 3 (42%).
• Over one-quarter (28%) of clients receiving intensive treatment received all 4 treatment types 
examined. This was a much larger proportion than for clients receiving either recurring (3.2%) or 
non-recurring (0.4%) treatment.
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What	main	treatment	types	did	clients	receive?	
Among clients who received intensive treatment, combinations of treatment including counselling 
and/or withdrawal management were the most common. For example, 2 in 5 (44%) clients with 
2 treatment types received counselling and ‘other’ treatment, 25% received counselling and 
withdrawal management, and 18% received withdrawal management and ‘other’ treatment  
(Table 4.2).
The most common treatment types were similar across all cohorts (Table 4.2):
• Among clients with 1 treatment type, counselling was the most common treatment for those 
receiving intensive (58%), recurring (76%) or non-recurring (50%) treatment.
• For clients with 2 treatment types, counselling and ‘other’ treatment was the most common 
combination for clients receiving intensive (44%), recurring (61%) or non-recurring (52%) 
treatment.
• Among clients receiving 3 treatment types, the most common treatment combination was 
counselling, withdrawal management and ‘other’ treatment for clients receiving intensive (57%), 
recurring (50%) or non-recurring (50%) treatment.
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Table	4.2:	Proportion	of	clients	by	number	of	main	treatment	types	and	main	
treatment type, clients with intensive, recurring or non-recurring treatment
Characteristics Intensive Recurring Non-recurring
Number	of	
treatment types
1 5.9 25.0 81.2
2 24.3 50.4 15.6
3 41.6 21.4 2.7
All 4 treatment types 28.2 3.2 0.4
Total 100.0 100.0 100.0
Clients with 1 
treatment type
Counselling 58.3 75.5 50.4
Withdrawal management 4.8 4.0 6.8
Rehabilitation 1.3 1.6 3.6
Other treatment 35.7 18.9 39.2
Total 100.0 100.0 100.0
Clients with 2 
treatment types













Rehabilitation and other 2.0 3.3 4.7
Total 100.0 100.0 100.0














Total 100.0 100.0 100.0
Notes
1.      Pharmacotherapy, support and case management only, and information and education only were included in the ‘other’ 
category. 
2.     Percentage distributions may not sum to 100 due to rounding.
Sources: Tables SC.10 and SC.11.
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4.3 Reason for cessation: planned or unplanned
What	were	the	reasons	for	cessation	by	clients?
Among clients who received intensive treatment, just under two-thirds (62%) of treatment episodes 
ended with a planned completion. This was a higher proportion than for clients who received 
recurring treatment (53% of episodes), but was similar to those who received non-recurring 
treatment (61%) (Figure 4.3; Table 4.3).
Among clients who received intensive treatment, almost 1 in 5 (19%) treatment episodes ended with 
an unplanned cessation. This was lower than for clients receiving recurring (27%) or non-recurring 
treatment (22%).
Figure 4.3: Proportion of episodes by reason for cessation, by treatment 








Note: ‘Other’ includes referral to another service, change in treatment mode, and other.
Source: Table SE.1
Did unplanned completion become more common in the last reported 
treatment	episode	compared	with	previous	episodes?
Clients receiving intensive treatment were more likely to end their last reported treatment episode 
in the study period with an unplanned cessation (26% of episodes) than their previous episodes 
(18%) (Table 4.3). Clients receiving recurring treatment also followed this pattern, being more likely 
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Table	4.3:	Proportion	of	episodes	ending	in	planned	or	unplanned	cessation	by	
clients receiving intensive, recurring or non-recurring treatment
Characteristics Intensive Recurring Non-recurring
% of all episodes by cessation 
reason
Planned completion 62.3 52.9 61.0
Unplanned completion 19.1 27.3 21.9
Other 18.6 19.8 17.1
Total 100.0 100.0 100.0
Total 100.0 100.0 100.0
% of last reported and previous 
episodes by cessation reason
% of last reported 
treatment episodes in 
the study period
Planned completion 59.2 53.9 62.6
Unplanned completion 26.3 31.1 22.9
Other 14.5 15.0 14.5
Total 100.0 100.0 100.0
% of previous episodes Planned completion 62.6 52.5 58.4
Unplanned completion 18.3 26.1 20.2
Other 19.1 21.3 21.4
Total 100.0 100.0 100.0
Notes
1.     ‘Other’ includes referral to another service, change in treatment mode, and other.
2.     Percentage distributions may not sum to 100 due to rounding.
Sources: Tables SE.1 and SE.2.
21Patterns of intensive alcohol and other drug treatment service use in Australia: 1 July 2014 to 30 June 2019
4.4 Were there patterns of service use among clients who  
	 received	intensive	AOD	treatment?
What	is	a	pattern	of	service	use?
A pattern of service use refers to a sequence of treatment across time. This includes patterns 
of characteristics across treatment episodes, such as PDOC, main treatment type and cessation 
reason. For example, a simple pattern might involve an episode of withdrawal management for 
alcohol as the PDOC, followed by an episode of counselling for alcohol (Lubman et al. 2014).
The AODTS NMDS captures a range of information about AOD treatment episodes, including PDOC, 













• The most common pattern (5.8% of clients) involved 3 episodes of counselling, all with a planned 
completion.
• The second most common pattern (3.7%) involved 3 episodes of withdrawal management, all 
with a planned completion.
• Each of the remaining patterns was followed by less than or equal to 1.7% of clients.
Analysis of clients who received intensive treatment for a PDOC other than alcohol (for example, 
amphetamines)	also	revealed	no	dominant	patterns	across	the	first	3	episodes.
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Figure	4.4:	The	most	common	initial	patterns(a) of treatment among clients 







at least 7 closed treatment episodes over the study period.
Clients who received intensive treatment 
for alcohol across all episodes (n=1,528)
Pattern 2 (3.7%) All other patterns 
(≤1.7%	each)
Pattern 1 (5.8%)
Episode 1: Alcohol, 
counselling, planned 
completion
Episode 2: Alcohol, 
counselling, planned 
completion
Episode 3: Alcohol, 
counselling, planned 
completion
Episode 1: Alcohol, 
withdrawal management, 
planned completion
Episode 2: Alcohol, 
withdrawal management, 
planned completion
Episode 3: Alcohol, 
withdrawal management, 
planned completion





A priority area for the AODTS NMDS is to examine the collection of treatment outcomes data. 
Outcome indicators may clarify why clients cease or continue treatment. For example, clients 
who receive non-recurring treatment may achieve their treatment goals after 1 or 2 episodes of 
treatment. Conversely, these clients may cease treatment prematurely due to barriers (for example, 
accessibility), despite experiencing ongoing symptoms of dependence. 
Collecting information about severity of dependence may also be used as an outcome indicator 
(that is, whether assessed in each episode and/or after treatment cessation), but could also help 
to inform the nature of treatment (intensive, recurring or non-recurring). For example, clients with 




AODTS NMDS data development activities could help to understand whether more treatment 
episodes are supporting clients to achieve their treatment goals. For example, the AODTS NMDS 
could seek to include treatment outcome data items in the data collection and monitor changes 
over time. This would enable future research to examine the reasons that clients cease or continue 
treatment,	and	how	they	differ	across	cohorts.
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6	 Conclusion
This report examined the characteristics of clients who received intensive AOD treatment in 
Australia over the 5-year period 2014–15 to 2018–19. It explored the sociodemographic and 
treatment characteristics of this cohort and compared it with cohorts that received either recurring 
or non-recurring treatment. This report also assessed patterns through treatment among clients 
who	received	intensive	treatment,	and	identified	common	factors	associated	with	receiving	
intensive treatment. 
Across all 3 treatment cohorts, clients were more likely to be male and non-Indigenous. However, 
clients who received intensive treatment were more likely to be female, non-Indigenous and live in 
the least socioeconomically disadvantaged areas than both other cohorts.
There was no dominant pattern of treatment service use among clients who received intensive AOD 
treatment. Treatment patterns involved many combinations of PDOC, main treatment types and 
cessation reasons. However, there were key characteristics that distinguished these clients from 
those receiving either recurring or non-recurring treatment.
Alcohol was the most common PDOC across all clients, irrespective of the treatment cohort, and 
counselling was the most common main treatment type. Clients who received intensive treatment 
were more likely to report multiple PDOC and multiple main treatment types across their treatment 
episodes than both other cohorts. They were also more likely to report planned completion for 
most or all of their treatment episodes than were clients with recurring treatment.
These	findings	indicate	that	clients	are	willing	to	make	repeated	efforts	to	seek	support	to	overcome	
problematic AOD use. Understanding these factors may help with treatment service planning.
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Appendix	A:	How	the	intensive	Alcohol	and	 
other	Drug	treatment	cohort	was	defined
The goal of this study was to explore the treatment patterns of a subset of clients who had received 
‘intensive’ treatment, conceptualised as treatment that took place across many episodes over a long 
period of time. This required the development of set criteria for how to classify any given series of 
treatment episodes.
From this goal, 2 broad criteria were developed: treatment across multiple years, and treatment 
across	many	episodes.	Each	of	these	criteria	required	specific	values	to	determine	the	treatment	
cohort.
Before establishing these treatment criteria, episodes of treatment for another person’s alcohol and 
other drug (AOD) use, or episodes with the main treatment type of ‘assessment only’ were removed. 
The	goal	of	this	paper	was	specifically	to	examine	people	accessing	treatment	for	their	own	AOD	
use, and the cohort of interest was people who had received many periods of direct AOD treatment 
over a long time, rather than many assessment episodes.
For the treatment across multiple years criterion, the goal was to choose the smallest possible 
number of collection periods in which treatment could occur for it to still be considered long term. 
As	a	result,	2	collection	periods	was	not	sufficient—a	person	may	have	received	2	episodes	of	
treatment, 1 in May and 1 in August of the same year, and they would fall into 2 collection periods.
The choice of treatment in at least 3 collection periods ensures that a person has returned to 
treatment multiple times, in episodes ending more than a year apart.
Criterion 1:	The	client	received	AOD	treatment	in	at	least	3	collection	periods.
The	non-recurring	cohort	was	defined	as	clients	who	did	not	fit	this	criterion;	that	is,	clients	who	
received treatment in 1 or 2 collection periods. Following the establishment of criterion 1, clients 
who	received	their	first	episode	of	treatment	in	2017–18	or	2018–19	were	also	removed,	as	it	was	not	
possible for them to appear in 3 collection periods.
The treatment across ‘many’ episodes criterion required a set number of episodes to be chosen 
as	a	cut-off.	To	address	the	question	of	what	this	cut-off	should	be,	the	number	of	episodes	that	
provided to each client who met criterion 1 was modelled to assess whether any number of distinct 
cohorts	could	be	identified.
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After considering factors such as the overall number of clients, the Australian Institute of Health 
and Welfare chose the largest number of episodes which captures the top 25% of clients (in terms 
of total number of episodes). In Figure A1, this is the line at 7 episodes—slightly more than 25% of 
clients received 7 or more closed treatment episodes between 2013–14 and 2018–19. 
Criterion 2:	The	client	received	an	overall	total	of	at	least	7	closed	treatment	episodes.
Clients who met both criteria were considered to have received ‘intensive treatment’, while clients 
who only met criterion 1 (that is, who received 3–6 treatment episodes) were considered to have 
received ‘recurring’ treatment.
This	outlines	the	method	of	defining	an	intensive	treatment	cohort.	Future	studies	that	may	use	a	
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Appendix	B:	Logistic	modelling	methodology	
and jurisdictional results
To ensure accurate representation of the alcohol and other drugs treatment service client 
population, logistic regression modelling was applied to collection period data between 2014–15 
and 2018–19. In particular, modelling was undertaken to determine whether known treatment and 
reporting	differences	between	states	and	territories	were	influencing	the	national	results	of	clients	
receiving intensive, recurring and non-recurring treatment (chapters 3 and 4).
Alcohol	and	other	drug	(AOD)	intensive	treatment
Intensive	AOD	treatment	was	defined	as	clients	who	received	7	or	more	closed	treatment	episodes	
across at least 3 collection periods between 2014–15 and 2018–19. This category was determined 
at the national level, where it represents the 75th percentile for the number of closed treatment 





on average, record more or fewer distinct treatment episodes, which in turn means that treatment 
may be more likely to be categorised as intensive in some jurisdictions than in others. For example, 
while 23% of the clients in the Alcohol and Other Drug Treatment Services National Minimum Data 
Set recorded treatment in Victoria, 43% of clients receiving intensive treatment were based in 
Victoria (Table B1). 
Table	B.1:	Proportion	of	clients	with	intensive	AOD	treatment	and	all	clients,	by	 
state	and	territory,	2014–15	to	2018–19
State/territory Clients receiving intensive treatment All clients
New South Wales 23.8 20.9
Victoria 42.7 22.6
Queensland 12.3 31.0
Western Australia 11.8 14.5
South Australia 3.2 4.6
Tasmania 1.0 1.9
Australian Capital Territory 4.0 2.4
Northern Territory 1.3 2.0
Total 100.0 100.0
Note: Percentage distributions may not sum to 100 due to rounding.
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Differences	between	jurisdictions	may	affect	the	generalisability	of	the	results.	For	example,	if	
clients receiving AOD treatment in 1 state tend to be older, and that state is more likely to have 
clients who received intensive treatment, then there may appear to be a relationship between age 
and	intensive	treatment	that	is	purely	caused	by	jurisdictional	differences.
To	ensure	differences	between	states	and	territories	are	not	causing	the	differences	between	clients	
receiving intensive, recurring and non-recurring treatment in chapters 3 and 4, a logistic model was 
applied. This model allows for exploration of the association between personal and treatment-level 
characteristics,	while	controlling	for	potential	confounding	effects	between	them.	By	controlling	
for state/territory in this model, it is possible to examine whether the other variables were still 
associated with intensive, recurring or non-recurring treatment.
The logistic regression modelling generally follows the results from the descriptive analyses 
reported	in	chapters	3	and	4.	For	example,	after	controlling	for	state/territory	differences,	
clients who received intensive treatment were more likely to be female and to live in the least 
socioeconomically disadvantaged areas than clients who received recurring or non-recurring 
treatment.
The model did disagree with some of the descriptive analysis. Before running the logistic regression 
model, clients who received intensive treatment included the highest proportion of clients who 
identified	as	non-Indigenous.	However,	this	was	no	longer	the	case	after	controlling	for	state/
territory in the logistic model, although clients who received non-recurring treatment did still have 
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Glossary
Alcohol: A central nervous system depressant made from fermented starches. Alcohol inhibits 
brain functions, dampens the motor and sensory centres and makes judgment, coordination, and 
balance	more	difficult.
Amphetamines: Stimulants that include methamphetamine, also known as methylamphetamine. 
Amphetamines speed up the messages going between the brain and the body.
Cannabis: Derivative from the cannabis plant (usually Cannabis sativa), which is used in whole 
plant	(typically	the	flowering	heads),	resin	or	oil	forms.	Cannabis	has	stimulant,	depressant	and	
hallucinogenic	effects.
Client	type:	The status of a person in terms of whether the treatment episode concerns their own 
alcohol and/or other drug use, or that of another person. Clients may seek treatment or assistance 
for their own alcohol and/or other drug use, or treatment and/or assistance for the alcohol and/or 
other drug use of another person.
Closed treatment episode: A period of contact between a client and a treatment provider, or team 
of providers. An episode is closed when treatment is completed, there has been no further contact 
between the client and the treatment provider for 3 months, or when treatment is ceased.
Heroin:	One of a group of drugs known as opioids, which are strong painkillers with addictive 
properties.	Heroin	and	other	opioids	are	classified	as	depressant	drugs.
Illicit	drug	use:	includes:
• the use of illegal drugs—drugs that are prohibited from manufacture, supply, sale or possession 
in Australia, such as cannabis, cocaine, heroin and ecstasy
• misuse, non-medical or extra-medical use of pharmaceuticals—drugs that are available from a 
pharmacy, over-the-counter or by prescription, which might be subject to misuse, such as  
opioid-based pain relief medications, opioid substitution therapies, benzodiazepines,  
over-the-counter codeine and steroids
• use of other psychoactive substances—legal or illegal drugs, potentially used in a harmful way, 
such as kava, or inhalants, such as petrol, paint or glue (but not including tobacco or alcohol).
Indigenous:	Person	of	Aboriginal	or	Torres	Strait	Islander	descent	who	identifies	as	an	Aboriginal	or	
Torres Strait Islander. 
Principal	drug	of	concern: The main substance that the client stated led them to seek treatment 
from an alcohol and drug treatment agency.
Remoteness	area: The Australian Bureau of Statistics’ Australian Statistical Geography Standard 
Remoteness	Area	classification	allocates	1	of	5	remoteness	categories	to	areas,	based	on	their	relative	
accessibility to goods and services (such as general practitioners, hospitals and specialist care) as 
measured	by	road	distance.	These	classifications	reflect	the	level	of	remoteness	at	the	time	of	the	
2011	Census.	Areas	are	classified	as	Major cities, Inner regional, Outer regional, Remote and Very remote.  
The remoteness area of the treatment service was derived from its Statistical Area Level 2 (SA2) 2011, 
while the remoteness area of the client was derived from the postcode of the client’s last known 
home address at the start of the treatment episode. When either the SA2 or the postcode covered 
multiple remoteness areas, the remoteness area allocation with the largest proportion was selected.
Treatment	episode:	The period of contact between a client and a treatment provider or a team of 
providers. Each treatment episode has 1 principal drug of concern and 1 main treatment type. If the 
principal drug or main treatment changes, then a new episode is recorded.
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Clients accessing alcohol and other drug treatment services 
often receive multiple episodes of treatment, with some 
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goals. This report describes 3 distinct client cohorts based on 
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